FNY Investment Advisers’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-477,823
| Closed | -$1.45M | – | 1025 |
|
|
2024
Q4 | $1.45M | Buy |
477,823
+294,323
| +160% | +$894K | 0.75% | 35 |
|
|
2024
Q3 | $952K | Buy |
+183,500
| New | +$952K | 0.46% | 64 |
|
|
2022
Q1 | – | Sell |
-15
| Closed | – | – | 912 |
|
|
2021
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 800 |
|
|
2020
Q1 | – | Sell |
-1,000
| Closed | -$16K | – | 826 |
|
|
2019
Q4 | $16K | Buy |
+1,000
| New | +$16K | 0.01% | 578 |
|
|
2019
Q3 | – | Sell |
-2,901
| Closed | -$37K | – | 1153 |
|
|
2019
Q2 | $37K | Buy |
+2,901
| New | +$37K | 0.01% | 401 |
|